Abstract Background: Antidepressants (ADs) are commonly prescribed medications, but
their long-term health effects are debated. ADs disrupt multiple adaptive processes …

Purpose This study aims to systematically review studies quantifying the associations
between antidepressants (ADs) use and the risk of cardiovascular (CV) outcomes. Methods …

Aims The association between antidepressant use and risk of cardiovascular disease (CVD)
remains controversial, particularly in initially healthy samples. Given that antidepressants …

Aims Our goal was to evaluate the association between antidepressant use and the risk of
coronary heart disease (CHD) among subjects with no history of coronary heart disease …

Background The association of antidepressant medication type with the risk of
cardiovascular disease (CVD) is unclear. We hypothesized that selective serotonin reuptake …

Objective: To examine whether selective serotonin reuptake inhibitor (SSRI) antidepressants
were associated with an increased or decreased risk of cardiovascular adverse events …

BACKGROUND Major depression or deterioration of previous mood disorders is a common
adverse consequence of coronary heart disease, heart failure, and cardiac revascularization …

PURPOSE: Several studies have found an increased risk of myocardial infarction among
depressed patients. Selective serotonin reuptake inhibitors (SSRIs) appear to lack the …

This manuscript reviews the evidence that depression is associated with increased risk of
mortality and explores the evidence that treating depression reduces that risk. The thought …

Expanding scientific evidence supports a long-recognized link between cardiovascular
disease and depression. As an independent risk factor, depression increases patient …